Clinical Trial Update: Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder

View source ↗

Summary

A completed clinical trial evaluating the Montreal Cognitive Assessment for validity in patients with mild and major neurocognitive disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Andreas Monsch | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Status: COMPLETED